• Profile
Close

Comparison of prostate cancer detection rates in patients undergoing MRI/TRUS fusion prostate biopsy with two different software-based systems

The Prostate Nov 10, 2021

Hanske J, Risse Y, Roghmann F, et al. - Findings demonstrate a likely substantial impact of robotic-driven software registration with elastic fusion on the detection of prostate cancer (PCa); an observation that is contrary to existing literature.

  • Using instructional retrospective biopsy data obtained between September 2013 and August 2017, a total of 241 men with at least one suspicious lesion [Prostate Imaging-Reporting and Data System  ≥  3 (PI-RADS ≥ 3)] on multiparametric MRI who had fusion prostate biopsy were included and analyzed.

  • Overall 1,048 targeted biopsy cores were performed by an experienced urologist; 45% cores were acquired via rigid processing, while the rest 55% cores depended on elastic image processing.

  • Higher odds of detecting clinically significant PCa (csPCa) were noted in relation to age, prostate-specific antigen, and PIRADS ≥ 3 lesion, in multivariable regression analyses.

  • Results showed an independent link of elastic software-based image processing with a higher overall PCa (odds ratio [OR] = 3.6 [2.2–6.1]) and csPCa (OR = 4.8 [2.6–8.8]) finding, respectively.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay